KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 129 filers reported holding KYMERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $431,012 | -40.0% | 31,008 | -0.8% | 0.00% | – |
Q2 2023 | $718,711 | -30.7% | 31,262 | -10.7% | 0.00% | – |
Q1 2023 | $1,037,495 | +25.4% | 35,015 | +5.6% | 0.00% | – |
Q4 2022 | $827,524 | +16.1% | 33,154 | +1.3% | 0.00% | – |
Q3 2022 | $713,000 | +26.2% | 32,730 | +14.0% | 0.00% | – |
Q2 2022 | $565,000 | -53.0% | 28,703 | +0.9% | 0.00% | – |
Q1 2022 | $1,203,000 | +38.3% | 28,445 | +107.6% | 0.00% | – |
Q4 2021 | $870,000 | +10.5% | 13,700 | +2.3% | 0.00% | – |
Q3 2021 | $787,000 | +142.9% | 13,395 | +100.6% | 0.00% | – |
Q2 2021 | $324,000 | +383.6% | 6,678 | +287.8% | 0.00% | – |
Q1 2021 | $67,000 | -38.5% | 1,722 | -1.4% | 0.00% | – |
Q4 2020 | $109,000 | – | 1,746 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
AtonRa Partners | 27,125 | $677,040 | 0.86% |
Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |